Beta Drugs Limited
Source: NSE · Updated 4 Nov, 06:28 pm IST
Numbers from the company's structured XBRL filing on NSE, cross-checked with P&L totals.
Previous-quarter and year-ago figures: as originally reported in those quarters' NSE filings; filing PDF not available to confirm restatements.
Quarter comparison
| Item | Q2 FY27 (Sep ’26) | Q1 FY27 (Jun ’26) | vs Q1 FY27 | Q2 FY26 (Sep ’25) | vs Q2 FY26 |
|---|---|---|---|---|---|
| Revenue from operations | 13,748.87 | 12,554.95 | ▲ 9.5% | — | — |
| Operating profit (EBITDA)* | 3,028.04 | 2,736.74 | ▲ 10.6% | — | — |
| Net profit | 1,928.45 | 1,648.56 | ▲ 17.0% | — | — |
| EPS (₹) | 16.59 | 14.78 | ▲ 12.2% | — | — |
| Operating margin | 22.0% | 21.8% | +20 bps | — | — |
| Net margin | 14.0% | 13.1% | +90 bps | — | — |
Showing Q2 FY27 (Sep ’26) and change vs Q2 FY26. Turn your phone sideways for Q1 FY27 (Jun ’26).
Figures in ₹ lakhs except EPS. Consolidated figures from the company's XBRL filing on NSE. Each row is shown only if it reconciles with the others (e.g. PBT − tax = net profit); rows we couldn't verify are left out. Net margin = net profit ÷ revenue. *Operating profit (EBITDA), derived from the filing: profit before exceptional items and tax + finance costs + depreciation − other income. Operating margin = EBITDA ÷ revenue.
All Beta Drugs results, dividends & filings ›Other results filed 22 Oct
FAQ
When did Beta Drugs announce Q2 FY27 results?
Beta Drugs filed its results on NSE on 22 Oct, 05:29 pm IST.
What does QoQ and YoY mean?
QoQ compares with the previous quarter; YoY compares with the same quarter last year. Growth is calculated from the figures in the filing.
Are these Beta Drugs figures official?
They are auto-read from the company's NSE filing and may contain errors. Always confirm with the official PDF linked on this page.
Explore
Figures are auto-read from the company's NSE filing and may contain errors. Check the official filing before deciding. Not investment advice.
← BETA overviewNothing matches.